Assessing the efficacy of PRP currently impossible


People with tendinopathy will continue to be offered non-evidence based treatments like plasma rich proteins until production processes for the procedure are standardised allowing high quality trials to be performed, the conference has heard. Speaking at a session called tendon pathology: controversies in treatment Dr Bethan Richards a rheumatologist at the RPA in Sydney told ...


Already a member? Login to keep reading


OR
© 2017 the limbic